Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
150%(6 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_1
5
63%
Ph phase_3
1
13%

Phase Distribution

5

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(4)

Detailed Status

Completed4
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (62.5%)
Phase 22 (25.0%)
Phase 31 (12.5%)

Trials by Status

terminated225%
completed450%
withdrawn225%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

NCT05401565
withdrawnphase_2

Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema

NCT05399550
withdrawnphase_1

The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan

NCT03912350
terminatedphase_3

A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension

NCT03504917
completedphase_1

A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers

NCT04156646
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05401565Phase 2

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Completed
NCT05399550Phase 2

Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema

Withdrawn
NCT03912350Phase 1

The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan

Withdrawn
NCT03504917Phase 3

A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension

Terminated
NCT04156646Phase 1

A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers

Completed
NCT04049578Phase 1

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder

Terminated
NCT03586726Phase 1

A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers

Completed
NCT03579719Phase 1

A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy Volunteers

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8